European Pharmaceutical Review

OCTOBER 18, 2022

billion by 2030, according to a market report. However, due to the small volumes required for dosage, small-scale providers are also gaining importance, findings from the report show. The Asia Pacific region is expected to register the fastest growth from 2022-2030 due to the presence of the large HPAPI manufacturers in China.

Dosage 105

Dosage Vaccines 105

European Pharmaceutical Review

OCTOBER 7, 2022

A market report has projected that the global oral solid dosage (OSD) contract manufacturing market is expected to be worth $54.7 billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 Leading companies in the oral solid dosage market are Catalent, Inc.,

Dosage 98

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 98

Express Pharma

NOVEMBER 26, 2024

With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare. Projections indicate exports will soar to $130 billion by 2030 and $450 billion by 2047. trillion.

Packaging 105

Packaging Biosimilars Pharmaceutical Manufacturing Dosage 105

Express Pharma

JANUARY 2, 2025

million by 2030. The post Akums announces new facility for lyophilized and sterile dosage manufacturing appeared first on Express Pharma. The global lyophilized injectables market, estimated at a value of approximately $ 3,365.4 million in 2023, is expected to experience steady growth, reaching an impressive $4,978.3 With a CAGR of 5.6

Dosage 52

Dosage Compounding 52

European Pharmaceutical Review

AUGUST 15, 2023

billion by 2030, according to a report from Data Bridge Market Research. According to the report buccal delivery is the “most feasible and preferred choice compared to oral dosage forms, particularly among elderly patients.” The sublingual films segment is projected to grow at the highest rate during the forecast period 2023-2030.

Dosage 52

Dosage Compounding 52

Express Pharma

JANUARY 17, 2025

As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. We have committed to reduce our scope 1 and 2 GHG emissions by 42 per cent (absolute) by the end of 2030 (from a 2021 basis).

Dosage 104

Dosage Pharmaceutical Manufacturing Packaging Drug Development 104

Express Pharma

MARCH 20, 2025

GlobalDatas report, Endometriosis Market Size and Trend Report, reveals that the endometriosis market size across the seven major markets* (7MM) is expected to achieve a compound annual growth rate of more than 9 per cent during 2020-2030.

Dosage 66

Dosage Compounding Hospitals 66